NCT02750384View on ClinicalTrials.gov

Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Healthy VolunteersBioavailability

Interventions

DRUG

DSM265 50% SDD granules

Single oral dose 400 mg

DRUG

DSM265 25% SDD powder for suspension

Single oral dose 400 mg

Trial Locations (1)

IL 60030

AbbVie Clinical Pharmacology Research Unit (ACPRU), Grayslake

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

Medicines for Malaria Venture

OTHER